Page last updated: 2024-09-05

sorafenib and Metabolic Diseases

sorafenib has been researched along with Metabolic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fehér, J; Lengyel, G	1

Reviews

1 review(s) available for sorafenib and Metabolic Diseases

Article	Year
[Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orvosi hetilap, 2010, Jun-06, Volume: 151, Issue:23 Topics: Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Hepatocellular; Copper; Developed Countries; Developing Countries; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Iron; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Neoplasms; Metabolic Diseases; Niacinamide; Phenylurea Compounds; Pyridines; Risk Factors; Smoking; Sorafenib	2010

Article

Year

[Hepatocellular carcinoma: occurrence, risk factors, biomarkers].

Orvosi hetilap, 2010, Jun-06, Volume: 151, Issue:23

Topics: Antineoplastic Agents; Benzenesulfonates; Biomarkers, Tumor; Carcinoma, Hepatocellular; Copper; Developed Countries; Developing Countries; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Iron; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Neoplasms; Metabolic Diseases; Niacinamide; Phenylurea Compounds; Pyridines; Risk Factors; Smoking; Sorafenib

2010